Stocks of Haleon plc (NYSE:HLN) traded higher last session on Wall Street, down -0.24% to $8.31.
According to the data, Haleon plc (NYSE:HLN) has 17 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $10.40 and a low of $7.11, we find $9.18. Given the previous closing price of $8.33, this indicates a potential upside of 10.2 percent. HLN stock price is now -1.01% away from the 50-day moving average and 3.43% away from the 200-day moving average. The market capitalization of the company currently stands at $37.49B.
A total of 6 analysts have issued a hold rating and 8 have given it a buy rating. Brokers who have rated the stock have averaged $9.06 as their price target over the next twelve months.
A total of 6.41% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HLN stock. A new stake in Haleon plc shares was purchased by HEATHBRIDGE CAPITAL MANAGEMENT LTD. during the first quarter worth $10,645,000. PORTSIDE WEALTH GROUP, LLC invested $6,022,000 in shares of HLN during the first quarter. In the first quarter, TWO SIGMA INVESTMENTS, LP acquired a new stake in Haleon plc valued at approximately $1,994,000. HOLOCENE ADVISORS, LP acquired a new stake in HLN for approximately $1,712,000. WCM INVESTMENT MANAGEMENT, LLC purchased a new stake in HLN valued at around $1,212,000 in the second quarter. In total, there are 637 active investors with 6.70% ownership of the company’s stock.
Thursday’s opening bell rang with an opening price of $8.47 for Haleon plc (NYSE: HLN). During the past 12 months, Haleon plc has had a low of $5.59 and a high of $9.05. As of last week, the company has a debt-to-equity ratio of 0.60, a current ratio of 0.80, and a quick ratio of 0.50. The fifty day moving average price for HLN is $8.40 and a two-hundred day moving average price translates $8.04 for the stock.
The latest earnings results from Haleon plc (NYSE: HLN) was released for Jun, 2023.
Moreover, the firm recently paid out its quarterly dividend on 10/05/2023. Investors who held shares on 08/25/2023 were paid a $0.0459936 dividend. On an annualized basis, this represents a $0.09 dividend and a 1.11% percent yield. There was an ex-dividend date of 08/24/2023 for this dividend.
Haleon plc(HLN) Company Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.
